Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
04/2006
04/13/2006CA2582658A1 Method for producing thioether compound
04/13/2006CA2582327A1 2-arylcarboxamide-nitrogeneous heterocycle compound
04/13/2006CA2580221A1 Novel cyclic and acyclic propenones for treating cns disorders
04/12/2006EP1645552A1 Double-spiro organic compounds and electroluminescent devices
04/12/2006EP1644321A2 New benzamides as ppaty modulators
04/12/2006EP1643961A2 Cox-2 and faah inhibitors
04/12/2006EP1075261B1 Mycobacterial inhibitors
04/12/2006EP1032555B1 Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
04/12/2006EP0903337B1 Process for the preparation of 1-alkoxycarbonyl-3-phenylpropyl derivatives
04/12/2006CN1757646A Inhibitors of nucleoside metabolism
04/12/2006CN1250528C Cyclic nitrones and pharmaceutical compositions containing them
04/12/2006CN1250526C Pyrrole substituted 2-indolinone protein kinase inhibitors
04/11/2006US7026500 Halogenated selective androgen receptor modulators and methods of use thereof
04/11/2006US7026498 Coordination catalyst containing ligand
04/11/2006US7026489 e.g., (9R)-1-{(2'S,8'S,10'S,11'R)-2',8'-dihydroxy-7'-oxo-11'-[(Z)-2-pentenyl]-9'-oxa-4'-azatricyclo[6.3.1.01.5]dodec-5'-en-10'-yl}-9-hydroxy-10-oxoundecanoic acid and N-[9-hydroxy-10-oxo-12(Z),15(Z)-octadecadienoyl]-L-isoleucine.
04/11/2006US7026488 A hemeoxygenase inhibitory metalloprotoporphyrin derivative, especially Zn-protoporphyrin, conjugated with an amphipathic or water soluble polymer; anticarcinogenic agents with little side effect and excellent tumor accumulation; very potent and efficient; administered by intravenous injection; stability
04/11/2006US7026476 Intermediate arylamine compounds
04/11/2006US7026358 Oral general anesthetics and metabolitically resistant anticonvulsants
04/11/2006US7026357 Diphenylurea compounds
04/11/2006US7026348 Antiinflammatory agents; sepsis shock; rheumatic diseases
04/11/2006US7026345 Resolution of 3-amino alkylnitriles
04/11/2006US7026339 Inhibitors of HCV NS5B polymerase
04/11/2006US7026318 Compounds exhibiting X-type sPLA2 inhibiting effect
04/11/2006US7026297 Neuroprotective agents
04/11/2006US7025949 In-vivo diagnostic method by means of near infrared radiation
04/11/2006CA2322558C Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel
04/11/2006CA2233842C Novel heterocyclic derivatives having indoline, indole or tetrahydroquinoline ring and pharmaceutical use thereof
04/11/2006CA2217030C Protease inhibiting succinic acid derivatives
04/11/2006CA2162382C Intercalators having affinity for dna and methods of use
04/11/2006CA2157128C Camptothecin derivatives, preparations thereof and antitumor agents
04/06/2006WO2006036994A2 Modulators of crth2, cox-2 and faah
04/06/2006WO2006035891A1 Isonitriles and antifouling agents against the adhesion of aquatics
04/06/2006WO2006035554A1 Heterocyclic compounds and optical recording materials
04/06/2006WO2006035308A1 Histamine-3 receptor antagonists
04/06/2006WO2006035286A2 Process for preparating enantiomerically pure fluvastatin sodium and a novel polymorphic form thereof
04/06/2006US20060074249 Processes of producing glutamic acid compounds and production intermediates therefore and novel intermediate for the processes
04/06/2006US20060074247 Improving storage stability by reacting with hydrogen sulfate lithium- containing compound; aspartyl protease inhibitors
04/06/2006US20060074231 Amino acid-containing compounds and derivatives labeled with halides and method of making
04/06/2006US20060074124 Using fused ring heterocyclic compounds such as 6-Chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxylic acid amide; neoplastic disorders, fat-cell related disorders, neurodegenerative disorders, and metabolic disorders such as diabetes; inhibitors of the deacetylase SirT1 protein sirtuin
04/06/2006US20060074114 Methods of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis using substituted indolealkanoic acids
04/06/2006DE102004047272A1 Inhibitoren der löslichen Adenylatzyklase Inhibitors of soluble adenylate cyclase
04/06/2006CA2581834A1 Novel crystal form of (3-cyano-1h-indol-7-yl)-[4-(4-fluorophenethyl)piperazin-1-yl]methanone, hydrochloride
04/06/2006CA2581741A1 Histamine-3 receptor antagonists
04/05/2006EP1331005B1 Medicinal compositions for concominant use as anticancer atent
04/05/2006EP1019372B1 Fused pyrrolecarboxamides; a new class of gaba brain receptor ligands
04/05/2006CN1756824A 有机电致发光元件 Organic electroluminescent element
04/05/2006CN1756742A Process for the preparation of 1,1,3,3-tetraalkylisoindolines starting from n-benzylphthalimide
04/05/2006CN1756734A Processes for producing glutamic acid derivative and pyroglutamic acid derivative and novel intermediate for production
04/05/2006CN1756553A 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof
04/05/2006CN1754880A Process for preparing 2-iminopyrrolidine derivatives
04/05/2006CN1754874A Process for preparing ropinirole and its salt
04/05/2006CN1754873A Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
04/05/2006CN1249210C Asymmetrical imide bleaching activators and compositions employing the same
04/05/2006CN1249034C Novel derivative of 2-azadicyclo-(2,2,1) heptane, its preparation and uses
04/04/2006US7022825 Polyketides and antibiotics
04/04/2006US7022786 Ligands, complexes and their use for the polymerization of olefins
04/04/2006US7022730 Protein tyrosine phosphatases inhibitors
04/04/2006US7022729 For treating central nervous system disorders, immunomodulatory disorders, antimalaria, viral disease of Borna virus, Hepatitis; a 6-azatricyclo(6.3.1.01,6)dodecane derivatives
04/04/2006US7022708 Serotonin receptors antagonis; antidepressants; central nervous system disorders; Parkinson's disease; huntington's disease; Alzheimer's disease
04/04/2006CA2256492C Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
04/04/2006CA2193039C Indol-2-one derivatives
04/04/2006CA2166315C Process for the preparation of thalidomide
03/2006
03/30/2006WO2006034390A2 Inhibitors of 15-lipoxygenase
03/30/2006WO2006034337A2 Carbazole and cyclopentaindole derivatives to treat infection with hepatitis c virus
03/30/2006WO2006034090A1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
03/30/2006WO2006033287A1 PHARMACEUTICAL COMPOSITION CONTAINING HMG-CoA REDUCTASE INHIBITOR AND GLUTATHIONE
03/30/2006WO2006032987A1 Indoline compounds and their use in the treatment of arteriosclerosis
03/30/2006WO2006032541A1 Indol derivatives as inhibitors of soluble adenylyl cyclase
03/30/2006WO2005123089A3 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease
03/30/2006WO2005120515A3 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
03/30/2006WO2005097107A3 Diphenyl - indol-2-on compounds and their use in the treatment of cancer
03/30/2006WO2005047899A3 Use of the lipoxin receptor, fprl1, as a tool for identifying compounds effective in the treatment of pain and inflammation
03/30/2006WO2004092346A3 Small molecule inhibition of a pdz-domain interaction
03/30/2006US20060069257 Use of specific bidentate ligands, e.g., 2-dicyclohexylphosphino-2'-dimethylamino-biphenyl, in transition metal-catalyzed carbon-heteroatom and carbon-carbon bond-forming reactions including amination and arylation and with aryl halide reactants and amine, boronic acid, borane or ketone reactants
03/30/2006US20060069256 Ophthalmic compositions for treating ocular hypertension
03/30/2006US20060069255 Novel aryl ureido benzoic acid derivatives and their use
03/30/2006US20060069148 Prostaglandins for prostaglandin mediated diseases such as antihistamines
03/30/2006CA2581492A1 Indol derivatives as inhibitors of soluble adenylyl cyclase
03/30/2006CA2580777A1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
03/30/2006CA2577413A1 Carbazole and cyclopentaindole derivatives to treat infection with hepatitis c virus
03/29/2006EP1640368A2 Cyclic ureas and processes for their preparation
03/29/2006EP1640361A2 Asymmetric urea compound and process for producing asymmetric compound by asymmetric conjugate addition reaction with the same as catalyst
03/29/2006EP1638956A1 2,3-substituted 5,6-diaryl-pyrazine derivatives as cb1 modulators
03/29/2006EP1638945A1 Heterocyclically substituted pentanol derivatives, method for the production thereof, and use thereof as anti-inflammatory agents
03/29/2006EP1638938A2 Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases
03/29/2006EP1638937A2 Fluvastatin sodium crystal forms xiv, lxxiii,lxxix, lxxx and lxxxvii, processes for preparing them, compositions containing them and methods of using them
03/29/2006EP1638612A2 Cox-2-targeted imaging agents
03/29/2006EP1492792B1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino¬4,5-b|indole-1-acetamide derivatives, preparation and use thereof in medicaments
03/29/2006EP1200395B1 Urea derivatives as inhibitors of ccr-3 receptor
03/29/2006EP1179342B1 Immediate release medicinal compositions for oral use
03/29/2006CN1753907A Method for synthesis of (2s,3as,7as)-1-((s)-alanyl)-octahydro-1h-indole-2-carboxylic acid derivatives and use in the synthesis of perindopril
03/29/2006CN1753906A Process for the synthesis of perindopril and its pharmaceutically acceptable salts
03/29/2006CN1753869A Method for synthesis of (2s,3as,7as)-perhydroindole-2- carboxylic acid and esters thereof, and use in the synthesis of perindopril
03/29/2006CN1753677A Ocular hypotensive agent
03/29/2006CN1752076A Preparation method of 2-azabicyclo[3,3,0] octane-1-carboxylic acid hydrochloride
03/29/2006CN1247589C Tricyclic derivatives of indole with antiangiogenic activity
03/29/2006CN1247587C Tert. alkylphenoxy substituted polycyclic compounds
03/29/2006CN1247574C Isoindolin-1-one glucokinase activators
03/29/2006CN1247528C Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same
03/29/2006CN1247190C Immediate release tablet cores of insoluble drugs having sustained release coating